We present a case of nesidioblastosis presenting with hyperinsulinaemic hypoglycaemia and electrocardiographic abnormalities.
Nesidioblastosis is a rare condition presenting with hyperinsulinaemic hypoglycaemia. It is probably inherited as an autosomal recessive trait."2 Pathologically, it is characterised by the finding of abnormal nests of endocrine tissue arising from pancreatic ducts.
Case report
A 40-year-old man was admitted to St Luke's Hospital on 7 February 1992 with a seven-day history of abdominal pain, vomiting, blurring of vision, lethargy and deteriorating urine output. On examination there was severe dehydration, a heart rate of 48 beats/min and a blood pressure of 90/60 mmHg. Urine output during the first 80 minutes was 16 ml; central venous pressure was 3 cm water; blood urea and creatinine peaked at 32 mmol/I and 250 umol/l, respectively. Serum potassium on admission was 5.9 mmol/l, haemoglobin concentration 16.8 g/dl and blood glucose 6 .67 mmol/l. The electrocardiogram (ECG) showed intermittent atrio-ventricular block with a junctional escape, and 3-4 mm downsloping ST segment depression in LI, aVL and V2-V6; T waves were upright (figure). The patient's condition improved with intravenous rehydration and temporary right ventricular endocardial pacing; all biochemical parameters l1 E I 1 1 1 1 1 1 1 S 1 1 I Figure Electrocardiographic tracing 6 -aminolevulinic acid and total porphyrins were normal. Ultrasound examination and computed tomography of the abdomen were also normal.
During the third hospitalisation the patient had repeated episodes of hypoglycaemia. Toxicology screen was negative. During one such episode of hypoglycaemia (3.0 mmol/l), serum insulin was 34.4 mU/l (reference range 2.8-13.5), C-peptide 1.01 nmol/l (0.18-0.52) and proinsulin 4.10 pmol/I (1.2-13.2). Serum insulin was estimated by radio-immunoassay (Pharmacia), C-peptide by an immunoassay (Incstar) and pro-insulin by an enzyme immunoassay.
Before these results were available, the patient died suddenly on 15 June 1992. Postmortem examination revealed a vitreous glucose level of 1.2 mmol/I and negative toxicology (including sulphonylureas and alcohol). The liver showed extensive fatty change with no evidence of hepatocellular necrosis or Mallory's hyaline. The pancreas was grossly normal. Microscopy revealed an increase in number and size of islets with foci of nesidioblastosis; no tumour could be found in spite of multiple sections. The heart was of normal size with no evidence of cardiomyopathy or ischaemic heart disease.
Galizia, Fava, Foale Discussion Our patient fulfilled the histological and biochemical criteria for a diagnosis of nesidioblastosis. Onset in adulthood has only rarely been reported. However, Fong et al suggest that it may be less rare than is commonly believed.3 Cases of hyperinsulinaemic hypoglycaemia in whom no insulinoma is demonstrated are often labelled as islet cell hyperplasia; it is possible that some of these may be due to nesidioblastosis that has been overlooked.
In our patient the major manifestations of recurrent hypoglycaemic episodes were electrocardiographic; there were conduction abnormalities and changes that are normally suggestive of ischaemia. Significant coronary artery disease was excluded angiographically. Hyperinsulinaemic states can be associated with a hypertrophic cardiomyopathy415; this is possibly related to the growth factor-like properties of insulin. However, there was no evidence of this in our patient on echocardiography, cardiac catheterisation or post-mortem studies. We believe that these electrocardiographic abnormalities were due to acute hypoglycaemia exacerbated in the initial presentation by volume depletion. These changes persisted even after correction (spontaneous or therapeutic) of hypoglycaemia. During the patient's first presentation blood glucose was normal on arrival at the emergency room; however, it is likely that there was a period of severe hypoglycaemia prior to arrival at hospital. We suggest that severe hypoglycaemia can result in prolonged electrocardiographic changes due to persistent intracellular hypoglycaemia or secondary metabolic abnormalities. Electrocardiographic changes have only rarely been reported in hypoglycaemia,68 
